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Background: Reviews have consistently shown that allocation 
concealment is frequently implemented and reported suboptimally in 
randomised controlled trials (RCTs). This research aims to pilot 
engaging with authors of RCTs to explore their knowledge and 
understanding of allocation concealment implementation and 
reporting to ascertain areas and mechanisms for their improvement. 
 
Methods: Authors that published RCTs in core clinical journals in one 
month in 2019 were identified. Authors were invited to complete 
questionnaires to elicit their views and experiences on the 
implementation and reporting quality focussing on allocation 
concealment. Methodological quality of allocation concealment was 
evaluated in this sample by assessing adherence to the Consolidated 
Standards of Reporting Trials (CONSORT). 
 
Results: Reporting was suboptimal, with only 57% of allocation 
concealment methods reported to be implemented which were 
judged as adequate, with 18% using sealed envelopes and more than 
40% not adequately reporting allocation methods. When exploring 
allocation concealment, implementation and reporting questionnaires 
were found to elicit a low response rate amongst authors of RCTs. 
 
Discussion: Following analysis of the themes that emerged from the 
questionnaires, the main recommendations to improve reporting 
quality are: journals need to endorse, adhere and promote reporting 
guidelines, a methodologist could review methodological details of 
publications simultaneously to peer review, envelopes as a form of 
allocation concealment are poorly implemented and reported, so 
careful review of these is required, funders need to insist on more 
robust allocation concealment methods are employed if the RCT 
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Introduction
Allocation concealment is a key criterion of quality for a rig-
orously conducted randomised controlled trial (RCT). It is the 
most basic methodological piece of information that should be 
reported1,2. Allocation concealment has been defined by the 
Consolidated Standards of Reporting Trials (CONSORT) 
group as:
‘A technique used to prevent selection bias by concealing 
the allocation sequence from those assigning participants to 
intervention groups, until the moment of assignment. Alloca-
tion concealment prevents researchers from (unconsciously or 
otherwise) influencing which participants are assigned to a given 
intervention group.’ Allocation Concealment, CONSORT.
A common misconception is that allocation concealment is the 
same as blinding3,4. Unlike allocation concealment, blinding 
is not always possible or even desirable to be carried out at all 
in RCTs5. This confusion may inadvertently lead to the use 
of poor allocation concealment. 
Historically, sequentially numbered, opaque, sealed, envelopes 
(SNOSE) were used to conceal allocation sequences and are 
still widely used. Despite descriptions of ‘relatively’ tamper 
proof methods using envelopes6 they can still be easily sub-
verted, such as by opening them in advance of patient recruit-
ment, therefore findings from RCTs using envelopes ought to be 
open to greater levels of scrutiny3,7. If envelopes are to be used 
then methods minimising tampering need to be put into place 
and reported. A more secure approach for allocation conceal-
ment is to use central randomisation– this is a method which is 
more difficult to subvert as it separates the randomisation 
sequence generation from the allocation of participants3,7. 
Research has shown that trials with inadequate or unclear 
allocation concealment are associated with increased effect 
sizes of greater than 40%1.
Unfortunately, RCT publications frequently do not report 
essential methodological factors in full, with many methodo-
logical elements, including allocation concealment, missing 
entirely4,8 In 1996 the CONSORT statement was published, 
after a growing body of evidence identified a lack of consist-
ent and high-quality reporting of RCTs9, with further revisions 
for different research designs8,10,11. Many, but not all, journals 
are now ‘CONSORT endorsing’ journals as they have adopted 
the CONSORT checklist for RCTs as a basic methodological 
checklist that authors should adhere to12. 
Research recognises that insecure allocation concealment 
methods are still being implemented and reporting is still sub-
optimal despite CONSORT13–16. An area that needs exploring 
is understanding why personnel involved in the conduct of 
RCTs are implementing insecure methods and why these meth-
ods are still not being properly reported. Engaging with this 
group will enable targeted recommendations to be made to 
improve both the implementation and reporting of allocation 
concealment.
Aims of this research
-  Pilot the use of a questionnaire to engage with 
authors of published RCTs to investigate their knowl-
edge and understanding of allocation concealment 
implementation and reporting.
-  Use these findings to ascertain areas and mecha-
nisms which are acceptable to these authors to 
improve implementation and reporting of allocation 
concealment.
-  Assess whether a questionnaire is an effective way to 
engage with authors of RCTs regarding methodological 
information to inform future research.
-  Determine the reporting quality of allocation conceal-
ment in this sample by assessing the adherence to 
CONSORT.
Methods
We identified all RCTs published in one month in 2019 in the 
‘Abridged Index Medicus’. We do not have ethical approval 
to specify the month that the articles are published as this would 
identify the authors invited to participate in the research and 
not keep their identities secure. We undertook double data 
extraction of the randomisation method and allocation con-
cealment method where the data was initially extracted and 
then second checked for any typological errors. We used this 
data to assess whether papers adhered to CONSORT. Table 1 
details the criteria used.
Table 1. Criteria used when judging randomisation and allocation concealment methods in included studies
Methodological 
factor
Methodological details determining the judgement
Randomisation 
method
This should be a truly random method to be adequate
Allocation 
concealment
Robust method used to conceal the randomisation sequence from all personnel involved in the study until after 
allocation has occurred. 
If envelopes were used as an allocation concealment method they are only judged as adequate if they were 
sequentially numbered sealed opaque envelopes (SNOSE), the personnel who created and opened them were both 
stated, and these were not the same person. 
Central randomisation was judged as adequate
Double-blind placebo-controlled trials were considered adequate as they are considered a robust trial design and 
difficult to subvert. 
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We contacted corresponding authors via the email address 
cited in the publication and asked them to anonymously fill in a 
short questionnaire17 assessing their views on trial reporting. 
The questionnaire consisted of two questions with closed 
responses and one open ended question. The purpose of this 
questionnaire was to establish if authors could define, and iden-
tify what were adequate methods of, allocation concealment. 
Participants were asked to leave their email address if they 
consented to fill in an in-depth 18 item questionnaire. Both ques-
tionnaires were created and distributed using QUALTRICS18. 
A reminder email was sent two weeks after the initial, requesting 
participation in the survey.
The purpose of the second questionnaire was to elicit compre-
hensive knowledge and views on implementation, reporting 
quality and mechanisms to improve trial reporting quality in 
relation to allocation concealment. 
Authors were sent the questionnaire and asked to respond 
within two weeks, after one week a reminder email was sent. 
The QUALTRICS survey was closed two months after the 
end date to ensure if there were late responses could still be 
submitted. For both questionnaires, where there were open/
free text boxes we performed a thematic analysis of the content 
of the questionnaire responses. The analysis was performed by 
LC and NM. Text was systematically examined, and themes 
identified by coding and categorising text according to key 
themes that emerged Data was initially organised in order to 
determine what participants knew about allocation conceal-
ment methodology, what method they had experience of using, 
if they knew what essential methodological information to 
report and what mechanisms could improve the reporting 
quality of RCTs and the opinions of suggestions to improve 
reporting quality of allocation concealment methodoloy These 
categories were further coded and mapped, as detailed partici-
pant responses were analysed to identify beliefs, experiences 
and barriers and facilitators to improving reporting quality, 
these lead to identifying and developing emergent themes. 
An internal pilot was performed on each questionnaire with 
research staff in the York Trials Unit who had experience of 
being authors of RCTs and trial methodology, following pilot-
ing we reordered some of the questions but did not change 
the content
Ethical approval was granted by the University of York Health 
Sciences Research Governance Committee in March 2019. 
Information regarding study information and the process of 
consent was provided at the start of the questionnaire, submis-
sion of the completed questionnaire by the participant was 
considered as implicit consent. We provided contact details to 
enable recipients of the questionnaire to contact the research 
team with any queries, advised them on the length of time the 
survey was expected to take, that all responses were anonymous 
and findings from the survey would be published.
Results 
In total, 95 RCTs were identified19, and 87% (n=83) were 
published in CONSORT endorsing journals. Of these, 94 had a 
corresponding author email address. The corresponding authors 
were a combination of clinicians and academics.
Assessment of allocation concealment reporting 
Of the identified RCTs, 75.8% (n = 72) reported the alloca-
tion sequence generation method and 71.6% (n =68) reported 
the allocation concealment method (see Table 2 for details), with 
CONSORT endorsing journals reporting these methodological 
details more frequently.
Table 3 shows that almost half of RCTs in CONSORT endors-
ing journals did not report with sufficient clarity that a judgement 
could be made as to the robustness of allocation concealment. 
It also indicates that 21.1% (n=20) were double blind placebo 
blind trials which were judged as adequate, of these only 60% 
(n=12) reported their allocation sequence generation method.
Allocation concealment methods: envelopes and 
central randomisation
Envelopes were used to conceal the allocation sequence in17.9% 
(n=17) of the included RCTs, with 52.9% (n = 9) describ-
ing the security of the envelope, 29.4% (n=5) stating who 
prepared the envelopes, and 35.3% (n=6) stating who opened 
the envelope. The reporting quality of necessary methodological 
information was poor for studies using envelopes; only 17.6% 
(n=3) were published adequately with all necessary informa-
tion to assess the methodological rigour reported. Central 
randomisation was performed in 33 (34.7%) RCTs.
Questionnaire analysis. In total, 12 (12.7%) anonymous 
authors returned the shorter questionnaire. The participants 
Table 2. Adherence to CONSORT when reporting 




Yes n(%) No n(%) Total n (%)
Allocation sequence 
generation method 
reported 65 (78.3) 7 (58.3) 72 (75.8)
Allocation concealment 
method reported 61 (73.5) 7 (58.3) 68 (71.6)
Table 3. Assessments of allocation concealment adequacy 





Yes n(%) No n(%) Total n (%)
Adequate n(%) 49 (59.1) 5 (41.6) 54 (56.8)
Unclear n(%) 34 (40.9) 7 (58.4) 41 (43.2)
Total n(%) 83 (87.4) 12 (12.6) 95 (100)
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had a varied range of experience of how many RCTs they had 
conducted. Most participants (n=8) had conducted >3 RCTs 
with one participant stating they had conducted >300 RCTs. 
Six authors (6.4%) consented to being sent the second larger 
questionnaire and five authors completed this. From examin-
ing the email addresses, one participant was a clinician and 
five were academics. Figure 1 shows the summary of response 
rates to the questionnaires.
Allocation concealment implementation
All participants would use both central randomisation serv-
ices and envelopes in future research. Of the participants, 80% 
(n = 4) believed that central randomisation should be the gold 
standard if appropriate to the trial design. Most participants 
supported the use of envelopes but did acknowledge that they 
were more at risk of subversion than central randomisation.
‘I would say for the envelopes they are adequate if they are 
SNOSE. While they are adequate they are rather impractical 
sometimes, and they are not completely immune to subversion of 
course. Central randomisation is therefore  
preferred’ (ID 2.5)
Participants were keen to emphasise that the choice of allocation 
concealment and randomisation is setting dependent.
‘In my experience, it [selection of allocation concealment method] 
is dependent on the type of setting; e.g. in a busy clinical ward 
with 24hr/7 recruitment, envelopes are far more user-friendly, 
especially when relying on busy clinical staff to take consent and 
randomise. Alternatively, in a 9–5pm environment, telephone or 
web-based can be applied easily’ (ID 2.2)
‘Envelopes [are chosen] because it was the next best thing in lieu 
of central randomisation for sites with poor internet connection 
etc. Central randomisation [is chosen] because it’s the best way’ 
(ID 2.5)
Envelope use
There was a large amount of support for the implementation of 
envelopes as an allocation concealment method where appro-
Figure 1. Summary of response rates to questionnaires.
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priate. The main reasons stated were trial setting, including the 
country and budget.
‘[Reasons for envelope use] for cases where you are running trials 
in LMICs [low and medium income countries] with, e.g. limited 
internet access - envelopes may be more practical. I also used 
them in an older trial which did not have funding for a central 
randomisation service. I would only use them for these niche cases 
and not as routine.’ (ID 2.5)
One participant selected that they did not think envelopes were 
an adequate allocation concealment method but they had used 
them in the past due to budget constraints.
Central randomisation
Central randomisation was accepted and described as being the 
‘best’ with no elaboration as to why. One author considered 
the problematic reporting of central randomisation.
‘Just saying its 'done centrally' [when reporting allocation con-
cealment methods implemented] I also find problematic. If you can 
call someone up to randomise and they have an open allocation 
list, there is still a risk that there is some collusion between the 
two parties to ensure certain patients are randomised one way or 
the other’ (ID 2.5)
Essential methodological information knowledge
We asked authors to list the top three methodological items 
to consider when conducting and reporting an RCT. Each 
response included the randomisation method employed with only 
one response stating that allocation concealment as important. 
Of the responses gained, 75% included blinding as an impor-
tant methodological item to report, which could suggest that 
blinding and allocation concealment are being confused as 
past research has highlighted3,4.
From the short questionnaire 60% of participants stated they 
could not define allocation concealment. The most general way 
of defining allocation concealment was to discuss how the ran-
domisation sequence should be hidden, but with no consid-
eration as to why as defined by CONSORT only one participant 
included selection bias in their response. 
‘If done effectively it [allocation concealment] should reduce the 
risk of selection bias by preventing researchers from manipulating 
when individual participants are enrolled/randomised based on 
prior knowledge of the upcoming randomisation sequence’ (ID 
1.1)
This suggests that many of those involved within the con-
duct of RCTs do not appear to see allocation concealment as an 
essential element to report.
There was a misconception that allocation concealment was 
the same as blinding the patients and outcome assessors by one 
participant, when asked to state what is important to report 
in RCTs.
‘Method of concealing the allocated treatments (blinding of 
patients and outcome assessors) [is important  
to report in RCTs]’ (ID 2.4)
Envelopes: methodology knowledge
We determined whether participants were aware of how to 
adequately implement and report envelopes in RCTs by ask-
ing them to state what essential methodological information 
is necessary. No author knew all essential quality factors to 
include within a publication. Only one participant stated that the 
individual who opened the envelope should be reported, and 
no authors stated that it was essential to report who prepared 
the envelopes. All participants knew that envelopes should be 
sequentially numbered, and that this should also be reported. 
Participants were mostly aware of additional security meas-
ures regarding the envelope that could be taken and reported to 
decrease the risk of subversion.
‘There are probably extra measures which may help to prevent 
subversion such as instructing staff to write the patient name etc. 
on the envelope prior to opening it, and ensuring that the seal is 
tamper proof - not e.g. a staple which can be carefully unpicked 
and re-stapled if someone was so motivated. A wax seal comes to 
mind although that sounds rather impractical too!’ (ID 2.5)
Investigator integrity emerged as a theme here, with participants 
claiming that investigators had to implement envelopes cor-
rectly but not acknowledging what needed to be reported. This 
also supports the theme that there is a lot of focus on trial con-
duct rather than trial reporting, this is discussed further on in 
this publication
‘Investigators have to use them [envelopes] properly. But inves-
tigators have to properly do all aspects of the trial. Basically, we 
always count on investigator integrity.’ (ID 2.3)
‘If I had to pick something [essential methodological information 
when reporting envelope use within an RCT] it would be processes 
to ensure adherence to correct use of the envelopes/prevent viola-
tion of the study protocol.’ (ID 2.1)
Improving reporting quality
Participants recognised that reporting quality needed improving, 
and different mechanisms were explored:
Role of journal editor. Of those surveyed, 80% (n=4) believed 
that the journal editor should ensure that key methodological 
information is reported within an RCT publication. It was also 
acknowledged that the editor does not necessarily have the 
expertise to do this.
‘Journal editors should do their best to review methodological 
information but if they don't have sufficient methodology expertise 
across all experimental designs that may be included in submis-
sions to their journal, then they are not the most appropriate 
person for this task’ (ID: 2.1)
Word limits imposed by journals. We asked participants if they 
thought word limits imposed by journals impacted the amount 
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of methodological information reported and thus the quality 
of the publication. There was agreement that although it could 
impact the quality, increasing the word count would most 
likely not help as the additional word limit may not be used to 
report the methodology.
‘Increasing journal word counts is merely one mechanism to 
facilitate (but not ensure) more comprehensive reporting of 
methods/findings. At authors discretion they could simply use the 
additional word count to expand their discussion’ (ID 2.1)
Pre-submission checks. We found there was minimal sup-
port from our surveyed population for journals to perform pre-
submission checks on a manuscript prior to full submission. 
We proposed that key methodological information of an RCT 
including allocation concealment and randomisation procedures 
were submitted to a journal for review. Only those manuscripts 
that include transparent and detailed methodological infor-
mation would then be invited to submit their full manuscript. 
This could lead to improved reporting quality of allocation 
concealment and randomisation methodology.
Linked to this was the criticism of journals and the time it takes 
for the peer review process to be completed. This influenced 
participant opinions when considering improvements to report-
ing quality. Although all participants agreed there was a need 
to increase reporting quality, they did not want to add any 
additional barriers to slow down publications.
‘It could add value but the length of the peer review process 
already substantially delays the release of scientific advances, and 
adding another rate-limiting step would exacerbate the delay’ 
(Paper ID 2.1)
‘All these points are important [to improve reporting quality] but I 
don't want more "process” [when trying to submit a manuscript to 
a journal]’ (ID 2.3)
Methodologist. The largest support was given to a method-
ologist always assessing the methods section of any publication 
submitted to a journal, similar to the statistical review some 
journals subject manuscripts to. Support was given to this if it 
was performed in a streamlined way and done simultaneously 
whilst the manuscript was going through the peer review process; 
participants were not supportive of any method of improve=ing 
trial reporting that they perceived to hold the process up further.
‘There is no reason why specialised methodology review could not 
be included as part of the standard external peer review process.’ 
(ID 2.1)
Role of Funders. Support for funders allocating specific fund-
ing for a third-party randomisation service if the RCT setting 
and design suited this emerged.
‘These [allocated funding for a third-party randomisation service] 
can help ensure robust methods before trial conduct, and thus the 
quality of the trial and report’ (ID 2.2)
There was also a suggestion for funding organisations to 
mandatorily require and fund external independent assessors
‘It would strengthen the robustness of any trial results if funding 
organizations would demand and financially support external 
independent assessors’ (ID: 2.4)
Both of these points however fail to recognise that robust 
trial design and methodology does not necessarily mean the 
RCT publication will be written to reflect this; these suggestions 
will not prevent poor reporting quality they only impact trial 
conduct. This theme is considered later in this manuscript.
Awareness of and adherence to guidelines
All participants stated that they used CONSORT guidelines 
when writing their RCT. Participants emphasised that some 
authors may not be aware of CONSORT, and that even though 
some journals do endorse the CONSORT statement there is a 
difference in how they are adhered to between journals which 
may impact reporting quality.
‘I think that many clinicians may be unaware of the full consort 
statement’ (ID 2.4)
‘Journals should adhere strictly to appropriate research reporting 
guidelines (e.g. CONSORT for RCTs)’. (ID 2.1)
There was universal support for CONSORT guidelines and 
strong agreement that there were adequate guidelines and sup-
port to aid the robust and transparent publication of research; 
rather it was adherence to the existing guidelines that is needed, 
with a focus on researchers ensuring this occurred. 
‘Guidelines for acceptable processes are readily available and 
reporting of that information is commonly required in key research 
reporting guidelines. If all researchers adhere to those recom-
mendations we should have very little risk of selection bias in 
published research…..Spend the effort/time/money advocating for 
better adherence to existing reporting guidelines.’ (ID 2.1)
Linked to this was that there were already mechanisms in place 
to enable trials to be reported adequately and that these need 
to be adhered to.
‘Many journals require submission of a supplementary document 
demonstrating adherence to an appropriate reporting guideline, 
which commonly directs readers to the appropriate section/page of 
a manuscript to find relevant information.’ (ID 2.1)
The translation of trial design and conduct to the 
publication
A recurring theme was the idea that if the trial was conducted 
robustly it would lead to a robust publication automatically. 
A lot of emphasis was placed on those researchers conduct-
ing themselves correctly, with integrity and following the 
protocol with the implication this would lead to a robust 
publication.
‘These options [suggestions to aid reporting quality] can help 
ensure robust methods before trial conduct, and thus the quality of 
the trial and report’ (ID 2.2)
‘[to improve reporting quality] ensure adherence to correct use of 
the envelopes/prevent violation of the study protocol’ (ID: 2.1)
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Discussion
Our research highlighted again that there is suboptimal imple-
mentation and reporting of allocation concealment. Only 57% 
of RCTs published in CONSORT endorsing journals contained 
adequate allocation concealment methods.
Analysis of the questionnaire data indicated that some authors 
could not accurately define allocation concealment, and it 
was at times confused with blinding. Only one participant 
considered it to be within the top three methodological ele-
ments of an RCT to report, indicating that it may not be reported 
adequately as it is not seen as a priority. 
To improve the reporting of allocation concealment there was 
support for a methodologist to review submitted articles to 
ensure essential methodological information was reported. 
There are a number of barriers to operationalise this particular 
mechanism. One solution could be to nominate a trial team 
member to be the guarantor for required methodological infor-
mation on submission of a manuscript, if journals do not have 
the capacity to support this specialist process.
The views of this sample of participants suggest that envelopes 
are going to be employed as a method of allocation conceal-
ment in future research for a variety of reasons such as budget, 
but authors had poor knowledge on which methodological 
factors should be reported.
Central randomisation was accepted as the gold standard but 
cost was a barrier for its implementation. Authors did not con-
sider that choosing a less expensive allocation concealment 
method could result in inadequate methods being employed, 
which, could lead to research that is judged as a high risk of 
bias20,21. We agree with the discussion point raised by a partici-
pant stating that randomisation that was ‘performed centrally’ 
does not give the reader enough information on what was carried 
out, this is suboptimal reporting.
RCT author engagement
This research demonstrated that a survey elicits a low response 
rate when engaging with authors regarding allocation con-
cealment knowledge, and different mechanisms to engage are 
needed. The corresponding author of a publication in health-
care is frequently a clinician and not a methodologist, which 
could explain the low response rate to a questionnaire about 
methodological information. We intentionally did not limit 
word counts within the free text boxes to enable full explo-
ration and elicitation of views, this enabled us to capture 
rich data. Despite the response rate the data was consistent 
amongst the participants, those that did respond showed high 
engagement with the topic and this has enabled a targeted 
list of recommendations to be made on improving the imple-
mentation and reporting of allocation concealment for this 
sample.
Limitations
There are many methodological quality factors that could have 
been addressed when assessing reporting quality. Nevertheless, 
allocation concealment was our focus due to it being the cen-
tral part of an RCT. There was a low response rate to the 
questionnaire with the majority of responses from academ-
ics rather than clinicians, which limits the generalisability of 
the findings amongst the RCT author population. The low sur-
vey response rate is a finding that has been observed in other 
research with a trend of decreasing participant engagement over 
time22–24, it is postulated that frequent survey requests and 
work schedules may influence participation, particularly with 
health professionals25. We did not repeat the survey to increase 
the sample size as an aim of this research was to assess the 
effectiveness of this method on author engagement, the 
response rate demonstrated that this method did not yield a high 
participation rate for this research area. 
Future research
Further work into how best to engage with RCT authors is 
necessary, interviews may be a better method to engage and 
unpick what is underpinning suboptimal implementation and 
reporting of allocation concealment. Identifying who is the 
methodologist within the author list and engaging with this 
individual may enable us to determine how the methods sec-
tion was written and reported and why poor reporting was occur-
ring by examining the internal editing processes that occurs 
within research teams, including any comments received 
from reviewers and methodological information that could 
have been lost during the publication process. Clinicians were 
under represented in this research, and exploring their views 
may elicit different mechanisms to improve allocation 
concealment implementation and reporting.
Work into exploring different mechanisms and reporting 
platforms where there is an instant publication and a transpar-
ent reviewing process is recommended (such as with F1000 
Research) which could lead to recommendations in speeding 
up reviewing time and processes which was highlighted as an 
issue with this surveyed sample.
Recommendations and conclusion
This research highlighted that there needs to be greater knowl-
edge of allocation concealment amongst authors of RCTs, as 
well as the understanding that securely implementing it does not 
automatically generate a well written RCT publication.
From the findings of this research to improve allocation 
concealment implementation and reporting we recommend:
-  CONSORT is endorsed and adhered to by each journal 
as it was accepted by all participants in this research 
-  Trials using envelopes need to be discouraged and if 
they are to be used then they should be robustly 
implemented and reported with careful checking 
that key methodological information is included in 
publications, as knowledge around this was suboptimal
-  Funders assess proposed methodology and insist on 
the use of robust allocation concealment methods if the 
RCT setting allows (such as central randomisation)
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-  If central randomisation is implemented full meth-
odological details are reported within the publication, 
including the names of external centres involved and 
the method of randomisation (simple, restricted) and 
details such as stratification variables and block 
size.
-  Authors need to take responsibility for ensuring key 
methodological factors are included in their RCT pub-
lications and should report all methods transparently 
even if not methodologically robust
-  A methodologist reviews the RCT publication to ensure 
key methodological information is included simul-
taneously to the peer review process. Although this 
is a recommendation based from the findings of this 
research the difficulties in the practicalities is discussed.
Data availability
Underlying data
Figshare: Methodological details of included studies
https://doi.org/10.6084/m9.figshare.13550348.v119
This project contains the following underlying data:
•    Methodological details of included studies.csv (Methodologi-
cal details reported in publications of randomised controlled 
trials included in the study).
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC BY 4.0).
We can only currently share the questionnaires sent to par-
ticipants and the non-identifiable data from the data extraction 
of the allocation concealment judgement where we identified 
included studies. We are only able to share the data extracted 
related to the journal CONSORT endorsement, quality judge-
ments we made on the allocation concealment methods and 
the breakdown of different methods used (such as central ran-
domisation and envelopes use), as to share the full extracted 
methods section and title from each included paper would enable 
the paper and therefore participants to be identified.
If readers or reviewers would like to apply for access to the 
data they would have to contact Laura Clark at laura.clark@
york.ac.uk. We are required to liaise with the University of York 
Health Sciences Research Governance Committee (https://
www.york.ac.uk/healthsciences/research-information/rsg/) to 
request permission to share the requested data and adhere to the 
conditions under which they will grant access.
Extended data
Figshare: Questionnaire to authors
https://doi.org/10.6084/m9.figshare.13550351.v117
This project contains the following extended data:
•    Questionnaires used in study.docx (Questionnaire sent to 
authors)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC BY 4.0).
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